MIP(L10A)
General Information
DRACP ID DRACP00276
Peptide Name MIP(L10A)
Sequence PRFWEYWLRAME
Sequence Length 12
UniProt ID Not available
PubChem CID Not available
Origin E3 ubiquitin-protein ligase
Type Synthetic peptide
Classification
Active ACP Cancer targeted peptides Affect cell cycle
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
-- | -- | -- | IC50 for MDM2=1.14 µM | ELISA assay | Not available | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target MDM2
Affinity Not available
Mechanism Inhibits MDM2-p53 Interaction
Nature Anticancer; Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C81H110N20O18S
Absent amino acids CDGHIKNQSTV
Common amino acids ERW
Mass 188032
Pl 6.53
Basic residues 2
Acidic residues 2
Hydrophobic residues 5
Net charge 0
Boman Index -2688
Hydrophobicity -86.67
Aliphatic Index 40.83
Half Life
Mammalian: >20 hour
Yeast: >20 hour
E.coli: ?
Extinction Coefficient cystines 12490
Absorbance 280nm 1135.45
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 21423613
Title mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction
Doi 10.1371/journal.pone.0017898
Year 2011
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available